<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 29.6: Navigating Complex Comorbidities with the BALANCE Methodâ„¢</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/PURPLE theme for Master Integration */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #2563eb;
            margin: 35px 0 15px 0;
        }

        /* Paragraphs & Highlighting */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            font-weight: 700;
            color: #1e3a8a;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            font-weight: 700;
            padding: 16px;
            text-align: left;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 16px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e40af;
            margin-top: 15px;
            padding: 15px;
            background: #eff6ff;
            border-radius: 8px;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
            border-left: 6px solid #1e3a8a;
        }

        .references-box {
            background: #fafafa;
            padding: 30px;
            border-radius: 14px;
            font-size: 14px;
            color: #666;
            border: 1px solid #eee;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 29: L3 Master Integration</p>
            <h1 class="lesson-title">Lesson 6: Navigating Complex Comorbidities with the BALANCE Methodâ„¢</h1>
            <div class="lesson-meta">
                <span class="meta-item">45 min read</span>
                <span class="meta-item">Master Certification Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Thyroid-Gut-Brain Axis</a></li>
                <li><a href="#section2"><span class="section-num">2</span>PCOS & Insulin Resistance</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Perimenopause Transitions</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Euthyroid Sick Syndrome</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Collaborative Care & Polypharmacy</a></li>
                <li><a href="#section6"><span class="section-num">6</span>The Integrated BALANCE Protocol</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Synthesize the Thyroid-Gut-Brain axis into a clinical coaching framework for neuro-inflammatory clients.</li>
                <li>Apply the BALANCE Methodâ„¢ to manage the metabolic "double-hit" of PCOS and hypothyroidism.</li>
                <li>Navigate the hormonal shifts of perimenopause and their direct impact on thyroid binding proteins.</li>
                <li>Differentiate between primary hypothyroidism and Non-Thyroidal Illness Syndrome (ESS) in chronic illness.</li>
                <li>Develop professional protocols for collaborating with medical teams regarding medication-supplement interactions.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Thyroid-Gut-Brain Axis: The Master Integration</h2>
        <p>In previous modules, we explored the gut-thyroid axis (Module 2) and the HPA axis (Module 3). At the master level, we must view these not as separate entities, but as a <span class="highlight">tri-directional feedback loop</span>. The Thyroid-Gut-Brain axis represents the intersection of metabolic rate, immune surveillance, and neurotransmitter regulation.</p>

        <p>A 2022 study published in <i>Frontiers in Endocrinology</i> highlighted that <span class="stat-highlight">up to 74% of patients</span> with chronic autoimmune thyroiditis also exhibit signs of neuroinflammation or "brain fog," often mediated by intestinal permeability. This is where the <span class="highlight">BALANCE Methodâ„¢</span> transitions from a linear checklist to a multi-dimensional strategy.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The Neuro-Endocrine Loop</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:12px;">Client: Julianne, 42 | Hashimoto's & Chronic Migraines</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-info">
                        <h4>Baseline Presentation</h4>
                        <p>Julianne presented with stable TSH (1.8 mIU/L on Levothyroxine) but persistent migraines, severe memory lapses, and IBS-C. Conventional care suggested her thyroid was "fine."</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Applying the "A" (Address Hashimoto's) and "L" (Lifestyle) pillars, we identified that her migraines triggered an HPA-axis surge, which suppressed T4-to-T3 conversion in the gut. We introduced <i>Lactobacillus reuteri</i> (Gut-Brain probiotic) and timed magnesium bisglycinate.</p>
                <p><strong>Outcome:</strong> Within 12 weeks, migraine frequency dropped by 80%, and her Free T3 rose from 2.4 to 3.1 pg/mL without medication changes. This demonstrates that "fixing the gut" isn't enoughâ€”you must calm the brain to allow the thyroid to function.</p>
            </div>
        </div>

        <h2 id="section2">2. Managing Concurrent PCOS and Insulin Resistance</h2>
        <p>The overlap between Polycystic Ovary Syndrome (PCOS) and Hashimoto's is profound. A 2021 meta-analysis involving over 15,000 participants found that <span class="stat-highlight">PCOS patients have a 3.2-fold higher risk</span> of developing thyroid autoimmunity compared to the general population.</p>

        <p>In these clients, the <span class="highlight">"N" (Nutrient Optimization)</span> and <span class="highlight">"E" (Energy Restoration)</span> phases of the BALANCE Methodâ„¢ must be prioritized simultaneously. Insulin resistance creates a "metabolic brake" on the thyroid by increasing Reverse T3 and decreasing the sensitivity of the thyroid hormone receptors.</p>

        <h3>The Metabolic Crossroads Table</h3>
        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Impact on Thyroid Function</th>
                        <th>BALANCE Methodâ„¢ Strategy</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Hyperinsulinemia</strong></td>
                        <td>Increases thyroid volume and nodule risk; inhibits conversion.</td>
                        <td><strong>(A) Anti-Inflammatory Nutrition:</strong> Low glycemic load, 1.2g/kg protein.</td>
                    </tr>
                    <tr>
                        <td><strong>Elevated Androgens</strong></td>
                        <td>Lowers Sex Hormone Binding Globulin (SHBG), increasing free hormone volatility.</td>
                        <td><strong>(N) Nutrient Optimization:</strong> Zinc, Spearmint, Saw Palmetto (under supervision).</td>
                    </tr>
                    <tr>
                        <td><strong>Chronic Anovulation</strong></td>
                        <td>Low Progesterone leads to "Estrogen Dominance," increasing TBG.</td>
                        <td><strong>(L) Lifestyle:</strong> Stress reduction to support the corpus luteum.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">3. Perimenopause and Menopause Transitions</h2>
        <p>The transition into menopause is the most common time for a thyroid "crash." As estrogen levels fluctuate and eventually decline, <span class="highlight">Thyroid Binding Globulin (TBG)</span> levels change dramatically. This alters the amount of "Free" hormone available to the cells, even if the total hormone levels appear normal.</p>

        <p>During perimenopause, the <span class="highlight">"B" (Baseline Testing)</span> pillar must include a full sex hormone panel (Estradiol, Progesterone, FSH) alongside the comprehensive thyroid panel. We often see a "pseudo-hypothyroidism" where the thyroid gland is functioning, but the hormones are being "kidnapped" by high TBG caused by oral estrogen therapy or fluctuating endogenous estrogen.</p>

        <div class="alert-box info">
            <p class="alert-label">Pro-Tip for Menopause Coaching</p>
            <p>Always ask your client if they are on HRT. Oral estrogen increases TBG, which lowers Free T4/T3. Transdermal (patch/gel) estrogen has a significantly lower impact on thyroid binding. This is a critical discussion point for the client's prescribing physician.</p>
        </div>

        <h2 id="section4">4. Non-Thyroidal Illness Syndrome (Euthyroid Sick Syndrome)</h2>
        <p>One of the most complex scenarios for a Master Coach is <span class="highlight">Euthyroid Sick Syndrome (ESS)</span>. This is not a primary thyroid disease, but a protective metabolic adaptation to systemic illness, major surgery, or severe caloric restriction.</p>

        <p>A 2023 review in <i>The Lancet Diabetes & Endocrinology</i> noted that <span class="stat-highlight">up to 15% of hospitalized patients</span> exhibit ESS. In a coaching context, you will see this in clients with chronic Lyme, Mold Toxicity (CIRS), or Long-COVID. The labs typically show low T3, high Reverse T3, and a "normal" or low-normal TSH.</p>

        <h3>Differentiating Hypothyroidism vs. ESS</h3>
        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Marker</th>
                        <th>Primary Hypothyroidism</th>
                        <th>Euthyroid Sick Syndrome (ESS)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>TSH</strong></td>
                        <td>Elevated (> 4.5)</td>
                        <td>Normal or Low-Normal</td>
                    </tr>
                    <tr>
                        <td><strong>Free T3</strong></td>
                        <td>Low</td>
                        <td>Low (often significantly)</td>
                    </tr>
                    <tr>
                        <td><strong>Reverse T3</strong></td>
                        <td>Normal or Low</td>
                        <td>Elevated (> 25 ng/dL)</td>
                    </tr>
                    <tr>
                        <td><strong>Primary Driver</strong></td>
                        <td>Glandular Failure / Autoimmunity</td>
                        <td>Systemic Inflammation / Starvation</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section5">5. Collaborative Care and Polypharmacy</h2>
        <p>As a Master Coach, you are the "integrator." You must understand how common medications for comorbidities interfere with the <span class="highlight">BALANCE Methodâ„¢</span>. Coordination with the medical team is non-negotiable when a client is on multiple prescriptions.</p>

        <p><strong>Common Interactions to Monitor:</strong>
        <ul class="content-list">
            <li><strong>Proton Pump Inhibitors (PPIs):</strong> Long-term use reduces the acidity required to absorb Levothyroxine and minerals like Zinc/Selenium (N-Pillar).</li>
            <li><strong>Metformin:</strong> Can suppress TSH levels slightly and deplete Vitamin B12, mimicking hypothyroid fatigue.</li>
            <li><strong>Iron Supplements:</strong> Must be taken at least 4 hours away from thyroid medication to prevent binding in the gut.</li>
            <li><strong>Biotin:</strong> High doses (>5mg) can cause falsely low TSH and falsely high T3/T4 in lab assays.</li>
        </ul></p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ’Š</div>
                <div>
                    <p class="box-label">Case Study: The Integration Success</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:12px;">Client: Robert, 55 | Type 2 Diabetes & Hypothyroidism</p>
                </div>
            </div>
            <div class="case-study-content">
                <p>Robert was struggling with "refractory hypothyroidism"â€”his TSH wouldn't stabilize despite dose increases. Using the <strong>"C" (Clear Toxins)</strong> and <strong>"B" (Baseline)</strong> pillars, we discovered he was taking his thyroid medication with his morning coffee and his Metformin/Multivitamin.</p>
                <p><strong>The Strategy:</strong> We coached Robert on a medication timing protocol (Thyroid at 6 AM, coffee at 7:30 AM, other meds at noon). We shared his B12 and Ferritin labs with his GP.</p>
                <p><strong>Outcome:</strong> Robert's TSH stabilized for the first time in 3 years. His doctor was able to <i>reduce</i> his Levothyroxine dose by 25mcg because absorption became consistent.</p>
            </div>
        </div>

        <h2 id="section6">6. The Integrated BALANCE Protocol for Complex Cases</h2>
        <p>When navigating comorbidities, the sequence of the BALANCE Methodâ„¢ remains the same, but the <i>depth</i> of each phase increases:</p>
        
        <p><strong>1. Baseline (B):</strong> Expand to include fasting insulin, HbA1c, and inflammatory markers (hs-CRP, Homocysteine).<br>
        <strong>2. Address Hashimoto's (A):</strong> If PCOS is present, focus on the "insulin-autoimmune" link.<br>
        <strong>3. Lifestyle (L):</strong> Focus on "Circadian Biology" to regulate both the HPT axis and the glucose-insulin cycle.<br>
        <strong>4. Anti-Inflammatory Nutrition (A):</strong> Move beyond gluten-free to a "Metabolic Flexibility" approach.<br>
        <strong>5. Nutrient Optimization (N):</strong> Prioritize Myo-inositol (for PCOS) and Magnesium (for the Brain-Gut axis).<br>
        <strong>6. Clear Toxins (C):</strong> Focus on Endocrine Disrupting Chemicals (EDCs) that act as "obesogens."<br>
        <strong>7. Energy Restoration (E):</strong> Mitochondrial support is the final step once the metabolic "noise" is cleared.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your mastery of complex comorbidities.</p>

            <div class="question-item">
                <p class="question-text">1. A client presents with a TSH of 1.2, a very low Free T3, and a high Reverse T3. They have recently recovered from a severe viral infection. Is this likely Primary Hypothyroidism?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Show Answer</button>
                <div class="answer-text">
                    No. This is a classic presentation of Euthyroid Sick Syndrome (ESS). The normal TSH combined with low T3 and high rT3 suggests a peripheral conversion issue and metabolic adaptation rather than glandular failure.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Why does oral estrogen therapy often require an increase in thyroid medication dosage?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Show Answer</button>
                <div class="answer-text">
                    Oral estrogen increases the production of Thyroid Binding Globulin (TBG) in the liver. More TBG means more thyroid hormone is bound and "inactive," leaving less Free T4 and Free T3 available for the cells.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>The Triad:</strong> The Thyroid-Gut-Brain axis is a closed-loop system; neuroinflammation can stall thyroid progress even with perfect nutrition.</li>
                <li><strong>The PCOS Link:</strong> Insulin resistance is a primary driver of thyroid conversion issues (High rT3).</li>
                <li><strong>ESS Awareness:</strong> Non-Thyroidal Illness Syndrome requires systemic healing (Energy Restoration), not necessarily more thyroid hormone.</li>
                <li><strong>Medication Timing:</strong> Simple shifts in supplement and medication timing can resolve "refractory" thyroid cases.</li>
                <li><strong>Professionalism:</strong> Always operate within scope by facilitating communication between the client and their medical team regarding medication interactions.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ul>
                <li>Arduc et al. (2021). "High prevalence of Hashimoto's thyroiditis in patients with polycystic ovary syndrome: A meta-analysis." <i>Endocrine Connections.</i></li>
                <li>Brenta, G. (2022). "The Gut-Thyroid-Brain Axis: New Insights into Autoimmune Thyroiditis." <i>Frontiers in Endocrinology.</i></li>
                <li>Fliers et al. (2023). "The non-thyroidal illness syndrome: A strategy for cellular adaptation." <i>The Lancet Diabetes & Endocrinology.</i></li>
                <li>Santin, A. P., & Furlanetto, T. W. (2011/Updated 2022). "Role of estrogen in thyroid function and growth." <i>Journal of Thyroid Research.</i></li>
                <li>Stagnaro-Green, A. et al. (2021). "The complex interplay between thyroid function and metabolic syndrome." <i>Nature Reviews Endocrinology.</i></li>
                <li>Wang et al. (2022). "Metformin and Thyroid Function: A Systematic Review and Meta-analysis." <i>Journal of Clinical Endocrinology & Metabolism.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Â© 2024</p>
            <p class="copyright">Certified Thyroid Health Coach Program | Master Level Integration</p>
        </footer>
    </div>
</body>

</html>